Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.

MLA

Sabbatini, Peter, et al. “Antitumor Activity of GSK1904529A, a Small-Molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 9, May 2009, pp. 3058–67. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-08-2530.

APA

Sabbatini, P., Rowand, J. L., Groy, A., Korenchuk, S., Liu, Q., Atkins, C., Dumble, M., Yang, J., Anderson, K., Wilson, B. J., Emmitte, K. A., Rabindran, S. K., & Kumar, R. (2009). Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(9), 3058–3067. https://doi.org/10.1158/1078-0432.CCR-08-2530

Chicago

Sabbatini, Peter, Jason L Rowand, Arthur Groy, Susan Korenchuk, Qi Liu, Charity Atkins, Melissa Dumble, et al. 2009. “Antitumor Activity of GSK1904529A, a Small-Molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15 (9): 3058–67. doi:10.1158/1078-0432.CCR-08-2530.